Search research articles
Contact Us
Filters
Showing results (1-10 of 27) with videos related to
Page
of 3
Sort By:
The Journal of Allergy and Clinical Immunology. in Practice
|
November 13, 2016
Assessing Quality of Life in Patients with Common Variable Immunodeficiency: Why It Matters
Daniel C Adelman, Kellee Howard
The New England Journal of Medicine
|
February 15, 2019
Oral Immunotherapy for Peanut Allergy
Brian P Vickery, Jonathan O Hourihane, Daniel C Adelman
Clinical Allergy and Immunology
|
October 2, 2001
Pharmacological approaches
Pedro C Avila, Jeffrey L Kishiyama, Daniel C Adelman
Investigational New Drugs
|
October 17, 2007
A phase 1 study of SNS-032 (formerly BMS-387032), a potent inhibitor of cyclin-dependent kinases 2, 7 and 9 administered as a single oral dose and weekly infusion in patients with metastatic refractory solid tumors
Elisabeth I Heath, Keith Bible, Robert E Martell, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
April 15, 2017
A Novel Patient-Derived Conceptual Model of the Impact of Celiac Disease in Adults: Implications for Patient-Reported Outcome and Health-Related Quality-of-Life Instrument Development
Daniel A Leffler, Sarah Acaster, Katy Gallop, et al.
The American Journal of Gastroenterology
|
February 21, 2018
Measuring Change In Small Intestinal Histology In Patients With Celiac Disease
Daniel C Adelman, Joseph Murray, Tsung-Teh Wu, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
November 1, 2002
Photodynamic therapy: applications in atherosclerotic vascular disease with motexafin lutetium
Tony M Chou, Kathryn W Woodburn, Wai-Fung Cheong, et al.
Gastrohep
|
April 22, 2020
Latiglutenase Treatment for Celiac Disease: Symptom and Quality of Life Improvement for Seropositive Patients on a Gluten-Free Diet
Jack A Syage, Peter H R Green, Chaitan Khosla, et al.
Gastroenterology
|
November 20, 2016
No Difference Between Latiglutenase and Placebo in Reducing Villous Atrophy or Improving Symptoms in Patients With Symptomatic Celiac Disease
Joseph A Murray, Ciarán P Kelly, Peter H R Green, et al.
Gastroenterology
|
March 4, 2014
Glutenase ALV003 attenuates gluten-induced mucosal injury in patients with celiac disease
Marja-Leena Lähdeaho, Katri Kaukinen, Kaija Laurila, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 27) with videos related to
Sort By:
Page
of 3
The Journal of Allergy and Clinical Immunology. in Practice
|
November 13, 2016
Assessing Quality of Life in Patients with Common Variable Immunodeficiency: Why It Matters
Daniel C Adelman, Kellee Howard
The New England Journal of Medicine
|
February 15, 2019
Oral Immunotherapy for Peanut Allergy
Brian P Vickery, Jonathan O Hourihane, Daniel C Adelman
Clinical Allergy and Immunology
|
October 2, 2001
Pharmacological approaches
Pedro C Avila, Jeffrey L Kishiyama, Daniel C Adelman
Investigational New Drugs
|
October 17, 2007
A phase 1 study of SNS-032 (formerly BMS-387032), a potent inhibitor of cyclin-dependent kinases 2, 7 and 9 administered as a single oral dose and weekly infusion in patients with metastatic refractory solid tumors
Elisabeth I Heath, Keith Bible, Robert E Martell, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
April 15, 2017
A Novel Patient-Derived Conceptual Model of the Impact of Celiac Disease in Adults: Implications for Patient-Reported Outcome and Health-Related Quality-of-Life Instrument Development
Daniel A Leffler, Sarah Acaster, Katy Gallop, et al.
The American Journal of Gastroenterology
|
February 21, 2018
Measuring Change In Small Intestinal Histology In Patients With Celiac Disease
Daniel C Adelman, Joseph Murray, Tsung-Teh Wu, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
November 1, 2002
Photodynamic therapy: applications in atherosclerotic vascular disease with motexafin lutetium
Tony M Chou, Kathryn W Woodburn, Wai-Fung Cheong, et al.
Gastrohep
|
April 22, 2020
Latiglutenase Treatment for Celiac Disease: Symptom and Quality of Life Improvement for Seropositive Patients on a Gluten-Free Diet
Jack A Syage, Peter H R Green, Chaitan Khosla, et al.
Gastroenterology
|
November 20, 2016
No Difference Between Latiglutenase and Placebo in Reducing Villous Atrophy or Improving Symptoms in Patients With Symptomatic Celiac Disease
Joseph A Murray, Ciarán P Kelly, Peter H R Green, et al.
Gastroenterology
|
March 4, 2014
Glutenase ALV003 attenuates gluten-induced mucosal injury in patients with celiac disease
Marja-Leena Lähdeaho, Katri Kaukinen, Kaija Laurila, et al.
Page
of 3